Cargando…
Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up
PURPOSE: To investigate whether circulating tumor DNA (ctDNA) assessment in patients with muscle-invasive bladder cancer predicts treatment response and provides early detection of metastatic disease. EXPERIMENTAL DESIGN: We present full follow-up results (median follow-up: 68 months) from a previou...
Autores principales: | Lindskrog, Sia V., Birkenkamp-Demtröder, Karin, Nordentoft, Iver, Laliotis, George, Lamy, Philippe, Christensen, Emil, Renner, Derrick, Andreasen, Tine G., Lange, Naja, Sharma, Shruti, ElNaggar, Adam C., Liu, Minetta C., Sethi, Himanshu, Aleshin, Alexey, Agerbæk, Mads, Jensen, Jørgen B., Dyrskjøt, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690087/ https://www.ncbi.nlm.nih.gov/pubmed/37782315 http://dx.doi.org/10.1158/1078-0432.CCR-23-1860 |
Ejemplares similares
-
Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
por: Christensen, Emil, et al.
Publicado: (2023) -
SPTAN1, APC, and FGFR3 Mutation Status and APOBEC Mutation Signatures are Predictive of Mitomycin C Response in Non-muscle-invasive Bladder Cancer
por: Lindgren, Maria Skydt, et al.
Publicado: (2021) -
Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
por: Taber, Ann, et al.
Publicado: (2020) -
Author Correction: Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
por: Taber, Ann, et al.
Publicado: (2022) -
Optimized targeted sequencing of cell-free plasma DNA from bladder cancer patients
por: Christensen, Emil, et al.
Publicado: (2018)